ImmunologyPharmacological ResearchPeer-reviewed
Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacy
Laura Grunewald, Lena Andersch, Konstantin Helmsauer…·Annette Künkele
This paper shows that high MYCN levels in neuroblastoma reduce L1CAM expression, limiting CAR T cell efficacy, and that inhibiting MYCN with MLN8237 restores L1CAM and enhances CAR T cell activity.
8 citations